2017
DOI: 10.1016/j.mcn.2017.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease

Abstract: CRISPR/Cas9 technology has transformed our abilities to manipulate the genome and epigenome, as applications have expanded from efficient genomic editing to include the targeted localization of effectors to specific genomic loci. By facilitating the manipulation of DNA- and histone-modifying enzyme activities, activation or repression of gene expression, and targeting of transcriptional regulators to defined loci, it is now possible to directly probe the role of gene-regulatory and epigenetic pathways in order… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
4
2
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 143 publications
0
14
0
Order By: Relevance
“…Personalized medicine is a rapidly progressing field with immense future potential in both diagnostics and therapeutics, especially given the recent advances in CRISPR/Cas9 genome‐editing technology . Identifying molecular and genetic biomarkers will have an impact on the field of cerebrovascular medicine.…”
Section: Discussionmentioning
confidence: 99%
“…Personalized medicine is a rapidly progressing field with immense future potential in both diagnostics and therapeutics, especially given the recent advances in CRISPR/Cas9 genome‐editing technology . Identifying molecular and genetic biomarkers will have an impact on the field of cerebrovascular medicine.…”
Section: Discussionmentioning
confidence: 99%
“…The CRISPR/Cas9 system can be used in a variety of ways to study neurological and psychiatric diseases in stem cell-based models ( 70 , 71 ). One particularly promising application is the manipulation of genetic material to explore the role of putative allelic variations in neurological and psychiatric conditions.…”
Section: Methods and Advances In Generating Hipsc-derived Neural Progmentioning
confidence: 99%
“…We hypothesized that C11orf46's affinity to the KMT-RC could be exploited, in order to 'edit' neuronal gene expression via a chromatin-associated mechanism. Such type of epigenome editing could be accomplished, for example, by RNA-guided fusion proteins comprised of nuclease-deficient clustered, regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein Cas9 (dCas9) bound to a transcriptional activator or repressor 38 .…”
Section: Supplementary Fig 3 and Supplementarymentioning
confidence: 99%
“…However, because '1:1' systems (one transcriptional regulator per dCas9 copy) are often only minimally effective 38,39 , we instead used dCas9-SunTag protein scaffolds which assembles as a binary system with the protein of interest fused to a single-chain antibody variable fragment (scFv)-green fluorescent protein cassette, with the scFv binding to the Cas9-fused protein scaffold carrying 10 or more copies of GCN4 (the scFv epitope) 39 . We built a dCas9-SunTag system to load ten copies of C11orf46, or the VP64 activator protein as a positive control, onto a single sgRNA-target sequence (Fig.…”
Section: Supplementary Fig 3 and Supplementarymentioning
confidence: 99%